The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
The Joint Corp.NASDAQ: JYNT
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 2.2% from a year ago
Cash & equivalents stood at $21.43M at the end of Q1 FY2026, down 2.2% from a year earlier and down 9.2% from the prior quarter. Over 3 fiscal years it compounded at +34.3% a year.
Context
- Cash & equivalents amounted to 37.0% of total assets at the end of Q1 FY2026, up 8.6 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -2.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 23.6M USD
- Year-over-year change
- -5.8%
- 4-year CAGR
- +4.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.6M | -5.8% |
| FY2024 | 2024-12-31 | 25.05M | +38.0% |
| FY2023 | 2023-12-31 | 18.15M | +86.3% |
| FY2022 | 2022-12-31 | 9.75M | -50.1% |
| FY2021 | 2021-12-31 | 19.53M | — |
Cash & Equivalents vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's Mar 2026 cash & equivalents of $21.43M is the 6th highest of the 11 companies compared; the peer median is $20.85M.
- Its year-over-year change of -2.2% is the 5th highest of 11, against a peer median of -23.6%.
- Cash & equivalents amounts to 37.0% of total assets for JYNT, versus a peer median of 19.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $49.57M | -32.5% | +168.5% | 28.6% | |
| Mar 2026 | $35.68M | -54.8% | -31.3% | 17.1% | |
| Mar 2026 | $31.14M | +0.4% | +46.0% | 49.4% | |
| Mar 2026 | $31.13M | +89.5% | -4.0% | 86.1% | |
| Mar 2026 | $27.88M | +10.5% | +15.6% | 81.8% | |
| Mar 2026 | $21.43M | -2.2% | +34.3% | 37.0% | |
| Mar 2026 | $13.82M | -26.9% | -9.5% | 22.2% | |
| Mar 2026 | $12.32M | +3.6% | +35.5% | 6.8% | |
| Mar 2026 | $5.32M | -87.2% | -32.7% | 6.0% | |
| Mar 2026 | $4.18M | -20.2% | -49.1% | 4.5% | |
| Mar 2026 | $3.85M | -43.4% | -36.7% | 4.4% | |
| Peer median (excluding JYNT) | $20.85M | -23.6% | -6.8% | 19.6% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 19.53M | 9.75M | 18.15M | 25.05M | 23.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.7M | 3.91M | 2.58M | 2.59M | 2.85M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.38M | 3.96M | 23.6M | 46.94M | 25.64M |
| Total Current Assets | 26.89M | 17.61M | 44.34M | 74.58M | 52.09M |
| Property, Plant & Equipment (Net) | 32.81M | 38.06M | 4.27M | 3.76M | 4.73M |
| Goodwill | 5.09M | 8.49M | 7.35M | 0 | 0 |
| Intangible Assets | 4.71M | 10.93M | 5.02M | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 11.49M | 11.93M | 1.03M | 0 | 0 |
| Other Non-current Assets | 6.07M | 6.46M | 25.19M | 4.81M | 4.15M |
| Total Non-current Assets | 60.17M | 75.88M | 42.87M | 8.58M | 8.88M |
| Total Assets | 87.06M | 93.49M | 87.21M | 83.15M | 60.97M |
| Account Payables | 1.71M | 2.97M | 1.25M | 1.75M | 1.59M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 8.43M | 10.43M | 2.52M | 2.55M | 2.8M |
| Other Current Liabilities | 925.72K | 1.4M | 27.37M | 39.2M | 22.68M |
| Total Current Liabilities | 21.44M | 23.22M | 33.57M | 49.04M | 32.82M |
| Long-term Debt | 2M | 2M | 2M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 57.15K | 0 | 0 |
| Deferred Revenue (Non-current) | 12.95M | 14.16M | 13.6M | 12.45M | 10.9M |
| Other Non-current Liabilities | 3.4M | 2.79M | 12.76M | 672.33K | 355.56K |
| Total Non-current Liabilities | 35.31M | 37.69M | 28.86M | 13.43M | 13.07M |
| Total Liabilities | 56.75M | 60.9M | 62.44M | 62.48M | 45.89M |
| Common Stock | 14.45K | 14.56K | 14.78K | 15.19K | 15.47K |
| Retained Earnings | (12.78M) | (12.15M) | (21.91M) | (27.7M) | (24.8M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 25K | 25K | 25K | 25K | 25K |
| Total Equity | 30.31M | 32.59M | 24.77M | 20.68M | 15.08M |
| Total Debt | 23.62M | 26.06M | 2.86M | 795.03K | 2.01M |
| Net Debt | 4.1M | 16.31M | (15.29M) | (24.26M) | (21.59M) |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.